Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
3.920
-0.050 (-1.26%)
At close: Nov 13, 2026, 4:00 PM EST
3.978
+0.058 (1.48%)
After-hours: Nov 13, 2026, 7:30 PM EST
Annexon Market Cap
Annexon has a market cap or net worth of $747.79 million as of November 13, 2026. It is the 11,726th most valuable company in the world and the 2,421st biggest in the United States. Its market cap has increased by 120.10% in one year.
Market Cap
747.79M
Enterprise Value
607.61M
1-Year Change
120.10%
Global Rank
Country Rank
#2,421 United States
Category
ChartMarket Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $747.79M, an increase of 16.93%. That is a compound annual growth rate of 2.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 747.79M | -0.06% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 796.97M |
| Ardelyx | 776.74M |
| Obsidian Therapeutics | 775.87M |
| Solid Biosciences | 763.42M |
| Prime Medicine | 761.98M |
| Aura Biosciences | 739.97M |
| Sagimet Biosciences | 729.38M |
| Alumis | 727.00M |